Form 4 holding
Chief Medical Officer
ROCKET PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 407,874
- Estimated value
- $1,549,921
- Report date
- 11 Feb 2026
- Price
- $3.80
- Ownership
- Direct
Syed Ali-Aamir Rizvi - Chief Medical Officer at ROCKET PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- RCKT, RCKTW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Syed Ali-Aamir Rizvi since 03 Jul 2025
Reported holdings for Syed Ali-Aamir Rizvi in ROCKET PHARMACEUTICALS, INC.
Form 4 holding
Chief Medical Officer
ROCKET PHARMACEUTICALS, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 93,037
- Estimated value
- Report date
- 11 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Syed Ali-Aamir Rizvi in ROCKET PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.